It looks like breast cancer prevention and therapy could become as easy as better screening and a shot in the arm.
Researchers at Cleveland Clinic say a breast cancer vaccine has shown promising results in animal studies, preventing cancer in a single shot.
If successful, the breast cancer vaccine will join two other cancer-preventive vaccines approved by The Food and Drug Administration (FDA): one against cervical cancer and the other against liver cancer.
While these vaccines target and kill the human papillomavirus (HPV) and the Hepatitis B virus (HBV) the breast cancer vaccine will focus on preventing cancer in healthy people and stopping growth of existing tumors.
The key is to find a target within the tumor not typically found in a healthy person. For breast cancer, Vincent Tuochy, Ph.D., the vaccine's principal investigator and an immunologist at Cleveland Clinic’s Lerner Institute and his research team chose α-lactalbumin.